Symbolbild · KI-generiert
Vitalhub Corp.
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub's comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.
Company description as published by the issuer via TMX Money.
Share price
Price data from TradingView, possibly delayed. Not investment advice.
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| Vitalhub Corp. | VHI | TSX | 309 Mio. USD |
| Sanara MedTech Inc. | SMTI | NASDAQ | 310 Mio. USD |
| Vanda Pharmaceuticals Inc. | VNDA | NASDAQ | 307 Mio. USD |
| Opus Genetics, Inc. | IRD | NASDAQ | 306 Mio. USD |
| Organogenesis Holdings Inc. | ORGO | NASDAQ | 305 Mio. USD |
| Cipher Pharmaceuticals Inc. | CPH | TSX | 305 Mio. USD |
| Scribe Therapeutics Inc. | SCTX | NASDAQ | 315 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.